Filters

60 Results

relevance


Zantac Heartburn Medication

Class Action

Zantac Heartburn Medication

In October 2019, a class-action lawsuit was filed against Sanofi-Aventis U.S., Sanofi US Services, Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals for allegedly failing to disclose that the over-the-counter heartburn medication…

Proactiv

Class Action

Proactiv

Allegations: Misleadingly representing that products were safe when they contain, or were at risk of containing, the carcinogen benzene

Mucinex Products

Class Action

Mucinex Products

Allegations: Falsely marketing that products provide relief from congestion, sinus pressure and other symptoms

Earache Medicines

Ad Alert

Earache Medicines

The FDA sent warning letters to four earache medication makers demanding that the companies stop marketing their products, which the FDA has determined to be prescription drugs, as over-the-counter medicine.…

VSL#3 Probiotic Medical Food

Class Action

VSL#3 Probiotic Medical Food

Allegations: Misleadingly using “VSL#3” in marketing after defendants lost the right to sell the proprietary formulation in 2016 and began selling an inferior formulation that had not been proven effective

Forest Laboratories Junk Fax

Class Action

Forest Laboratories Junk Fax

A class-action lawsuit filed against Forest Laboratories, Inc. in November 2012 alleges that the company sent the St. Louis Heart Center 40 junk faxes, all trying to sell Forest’s hypertension…

AstraZeneca Nexium

Class Action

AstraZeneca Nexium

A group of consumers who purchased Nexium, a heartburn medication, in Massachusetts since March 2001 filed a class-action lawsuit against AstraZeneca.  They claimed that the pharmaceutical company deceptively marketed the…

Coppertone Water Babies

Class Action

Coppertone Water Babies

Allegations: Marketing sunscreens as “safe and gentle on a baby’s skin” when they contain the carcinogen benzophenone

Show More